The neurochemistry of phenylketonuria.
The mechanisms by which deficiency of hepatic phenylalanine hydroxylase causes central nervous system disease are reviewed. The neurological disease appears to be secondary to increased concentrations of phenylalanine and a decrease in the concentrations of other large neutral amino acids, especially methionine and tyrosine, within the central nervous system. This causes a deficiency of the neurotransmitter dopamine, reduced protein synthesis and demyelination. Similar mechanisms appear to be operating when blood phenylalanine concentrations are in the range expected for early continuously treated phenylketonuria.


CONCLUSIONS
The severe brain disease found in phenylketonuria is caused by a raised blood phenylalanine content which increases the brain free phenylalanine and decreases the concentration of other large neutral amino acids. Brain protein synthesis is decreased, myelin turnover is increased and there are abnormalities in amine neurotransmitter systems.
Surtees
R
R
Institute of Child Health (UCLMS), London, UK. r.surtees@ich.ucl.ac.uk
Blau
N
N
D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000502:physiology*; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D009186:Myelin Sheath / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D010661:Phenylketonurias / Q000378:metabolism*
D000596:Amino Acids; D009419:Nerve Tissue Proteins; D004298:Dopamine